Section Summary

• The window of opportunity describes a chance to control inflammation before irreversible damage accumulates; it is not a guaranteed deadline or outcome.
• Trajectory matters more than a single lesion count: recurrence, distribution, treatment response, structural change, and patient burden must be integrated.
• Persistent activity, frequent flares, inadequate control, new tunnels or scars, and significant functional burden should prompt active reassessment.
• Escalation may involve diagnosis review, treatment optimization, advanced therapy, procedural care, or dermatology coordination—not automatically one specific medication.
• Non-dermatologists can protect the window through early recognition, complete documentation, timely referral, and continuity of care.